(READ) Congress Probes Pfizer, Merck over Clinical Trials in China

(READ) Congress probes Pfizer, Merck over clinical trials in China

The following information is from Children’s Health Defense. Rep. John Moolenaar  (R-Mich.), chairman of the House Select Committee on China, has launched an investigation into clinical trial sites in China used by several major pharmaceutical companies, including Pfizer, Merck, Bristol Myers Squibb, AbbVie and Eli Lilly. Late last month, Moolenaar sent letters to the companies requesting information about their research activities in China. The…

U.S. House committee investigates pharmaceutical giants for clinical trials at Chinese military hospitals

A bipartisan House committee is investigating Pfizer, Merck, AbbVie, Eli Lilly and Bristol Myers Squibb for clinical trials conducted at Chinese military-linked hospitals and in Xinjiang The probe focuses on national security risks, ethical concerns and potential intellectual property theft China has surpassed the U.S. in early-stage drug development volume since 2024 Lawmakers question whether […]